SJS Investment Consulting’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
SJS Investment Consulting's ADMA Position: Q3 2026 in Review
SJS Investment Consulting increased its ADMA Biologics (ADMA) stake by 565% in Q3 2026, buying an estimated $13.3K and bringing the position to 1,696 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.
SJS Investment Consulting first reported a position in ADMA in Q3 2024 and has held it in 9 quarters since. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- SJS Investment Consulting held 1,696 shares of ADMA Biologics worth $17K as of Q3 2026.
- SJS Investment Consulting bought 1,441 ADMA Biologics shares in Q3 2026, an estimated $13.3K.
- ADMA Biologics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1074 holding.
- SJS Investment Consulting first reported a position in ADMA Biologics in Q3 2024 and has held it in 9 quarters since.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.